science
CRISPR uncovers drug resistance gene
Australian researchers have used a new CRISPR activation tool to identify a previously unknown gene involved in resistance to a widely used blood cancer drug, as well as several genes linked to accelerated lymphoma growth. Researchers from the Olivia Newton-John Cancer Research Institute (ONJCRI), WEHI and Genentech used the clustered regularly interspaced short palindromic repeats [...]
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Clearing the Path: Mars Launches Pet Adoption Resource Hub, as New Research Reveals What Holds Adopters Back | AAP
Australian Associated Press
Clearing the Path: Mars Launches Pet Adoption Resource Hub, as New Research Reveals What Holds Adopters Back
Australian Business Announcements
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment | AAP
Australian Associated Press
Is Zelira Therapeutics Ltd (ASX:ZLD) Gaining Attention as Cannabis Research and Product Development Shape the Session?
Kalkine Media
Astronomers produce the first complete picture of (gas) planet formation in action
The National Tribune